Amgen Inc (AMGN)
268.94
+6.20
(+2.36%)
USD |
NASDAQ |
Apr 19, 16:00
270.75
+1.80
(+0.67%)
After-Hours: 20:00
Amgen Cash and Short Term Investments (Quarterly): 10.94B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.94B |
| September 30, 2023 | 34.74B |
| June 30, 2023 | 34.25B |
| March 31, 2023 | 31.56B |
| December 31, 2022 | 9.305B |
| September 30, 2022 | 11.48B |
| June 30, 2022 | 7.183B |
| March 31, 2022 | 6.544B |
| December 31, 2021 | 8.037B |
| September 30, 2021 | 12.92B |
| June 30, 2021 | 8.082B |
| March 31, 2021 | 10.57B |
| December 31, 2020 | 10.65B |
| September 30, 2020 | 12.36B |
| June 30, 2020 | 11.42B |
| March 31, 2020 | 8.012B |
| December 31, 2019 | 8.911B |
| September 30, 2019 | 20.85B |
| June 30, 2019 | 21.76B |
| March 31, 2019 | 26.30B |
| December 31, 2018 | 29.30B |
| September 30, 2018 | 29.92B |
| June 30, 2018 | 29.40B |
| March 31, 2018 | 32.17B |
| December 31, 2017 | 41.68B |
| Date | Value |
|---|---|
| September 30, 2017 | 41.35B |
| June 30, 2017 | 39.23B |
| March 31, 2017 | 38.40B |
| December 31, 2016 | 38.08B |
| September 30, 2016 | 37.98B |
| June 30, 2016 | 35.03B |
| March 31, 2016 | 34.74B |
| December 31, 2015 | 31.38B |
| September 30, 2015 | 31.12B |
| June 30, 2015 | 29.99B |
| March 31, 2015 | 27.12B |
| December 31, 2014 | 27.03B |
| September 30, 2014 | 28.08B |
| June 30, 2014 | 26.19B |
| March 31, 2014 | 19.80B |
| December 31, 2013 | 19.40B |
| September 30, 2013 | 22.56B |
| June 30, 2013 | 22.02B |
| March 31, 2013 | 21.27B |
| December 31, 2012 | 24.06B |
| September 30, 2012 | 25.37B |
| June 30, 2012 | 22.48B |
| March 31, 2012 | 19.37B |
| December 31, 2011 | 20.64B |
| September 30, 2011 | 17.68B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
6.544B
Minimum
Mar 2022
34.74B
Maximum
Sep 2023
14.71B
Average
10.94B
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Gilead Sciences Inc | 7.264B |
| Johnson & Johnson | 22.93B |
| Eli Lilly and Co | 2.928B |
| Merck & Co Inc | 7.093B |
| Vertex Pharmaceuticals Inc | 11.22B |